Effects of TGF-β on eosinophil chemotaxis

Scandinavian Journal of Immunology

Volumn 47, Issue 2, 1998, Pages 127-130

  Luttmann, W ^a   Franz, P ^a   Matthys, H ^a   Virchow Jr , J C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; PROPIDIUM IODIDE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL MIGRATION; CELL SURVIVAL; CELL VIABILITY; CHEMOTAXIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031912524     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00298.x     Document Type: Article

References (32)

1. Walker C, Virchow JC, Jr., Bruijnzeel PL, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991;146:1829-1835.
2. Lopez AF, Vadas MA, Woodcock JM et al. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 1991;266:24741-24747.
3. Owen WF, Rothenberg ME, Petersen J et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989;170:343-8.
4. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, 1L-6, and GMCSF. Blood 1989;73:1504-1512.
5. Kato M, Liu MC, Stealey BA et al. Production of granulocyte/ macrophage colony-stimulating factor in human airways during allergen-induced late-phase reactions in atopic subjects. Lymphokine Cytokine Res 1992;11:287-92.
6. Corrigan CJ, Haczku A, Gemou-Engesaeth V et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993;147:540-7.
7. Virchow JC, Jr., Walker C, Hafner D et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
8. Warringa RA, Koenderman L, Kok PT, Kreukniet J, Bruijnzeel PL. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991;77:2694-2700.
9. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-50.
10. Wahl SM, Hunt DA, Wong HL, Dougherty S et al. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 1988;140:3026-32.
11. Adams DH, Hathaway M, Shaw J, Burnett D, Elias E, Strain AJ. Transforming growth factor-β induces human T lymphocyte migration in vitro. J Immunol 1991;147:609-12.
12. Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-β 1 mediates mast cell chemotaxis. J Immunol 1994;152:5860-7.
13. Fava RA, Olsen NJ, Postlethwaite AE et al. Transforming growth factor β 1 (TGF-β 1) induced neutrophil recruitment to synovial tissues: implications for TGF-β-driven synovial inflammation and hyperplasia. J Exp Med 1991;173:1121-32.
14. Brandes ME, Mai UE, Ohura K, Wahl SM. Type I transforming growth factor-β receptors on neutrophils mediate chemotaxis to transforming growth factor-β. J Immunol 1991;147:1600-6.
15. Reibman J, Meixler S, Lee TC et al. Transforming growth factor β 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci USA 1991;88:6805-9.
16. Parekh T, Saxena B, Reibman J, Cronstein BN, Gold LI. Neutrophil chemotaxis in response to TGF-β isoforms (TGF-β 1, TGF-β 2, TGF-3) is mediated by fibronectin. J Immunol 1994;152:2456-2466.
17. Fava RA, McKanna J, Cohen S. Lipocortin I (p. 35) is abundant in a restricted number of differentiated cell types in adult organs. J Cell Physiol 1989;141:284-93.
18. Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Makino S. Detection of transforming growth factor-β in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay. Clin Exp Allergy 1996;26:557-62.
19. Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factors-α and β 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994;93:864-9.
20. Kadin M, Butmarc J, Elovic A, Wong D. Eosinophils are the major source of transforming growth factor-β 1 in nodular sclerosing Hodgkin's disease. Am J Pathol 1993;142:11-6.
21. Ohno I, Lea RG, Flanders KC et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor β 1 gene (TGF β 1). J Clin Invest 1992;89:1662-1668.
22. Wong DT, Donoff RB, Yang J et al. Sequential expression of transforming growth factors α and β 1 by eosinophils during cutaneous wound healing in the hamster. Am J Pathol 1993;143:130-42.
23. Wong DT, Elovic A, Matossian K et al. Eosinophils from patients with blood eosinophilia express transforming growth factor β 1. Blood 1991;78:2702-7.
24. Alam R, Forsythe P, Stafford S, Fukuda Y. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994;179:1041-5.
25. Atsula J, Fujisawa T, Iguchi K, Terada A, Kamiya H, Sakurai M. Inhibitory effect of transforming growth factor β 1 on cytokine-enhanced eosinophil survival and degranulation. Int Arch Allergy Immunol 1995;108:31-5.
26. Hansel TT, De Vries IJ, Iff T et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-10.
27. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-9.
28. Owen WF, Jr., Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, Austen KF. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol 1987;138:532-8.
29. Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7:631-6.
30. Sillaber C, Geissler K, Scherrer R et al. Type β transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils. Blood 1992;80:634-41.
31. Magnan A, Frachon I, Rain B et al. Transforming growth factor β in normal human lung: preferential location in bronchial epithelial cells. Thorax 1994;49:789-92.
32. Bittleman DB, Erger RA, Casale TB. Cytokines, Neutrophil, Eosinophil, Chemotaxis. Cytokines induce selective granulocyte chemotactic responses. Inflammation Research 1996;45:89-95.